Macrophages promote anti-androgen resistance in prostate cancer bone disease
Journal of Experimental Medicine · 2023
DOI: 10.1084/jem.20221007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2023. Verfasst von Xue-Feng Li und 21 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Reproductive Health, College of Medicine and Veterinary Medicine, Queen's Medical Research Institute, The University of Edinburgh , Edinbu…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Bone Neoplasms. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Howard Hughes Medical Institute, NCI NIH HHS.
Abstract (Originalsprache)
Metastatic castration-resistant prostate cancer (PC) is the final stage of PC that acquires resistance to androgen deprivation therapies (ADT). Despite progresses in understanding of disease mechanisms, the specific contribution of the metastatic microenvironment to ADT resistance remains largely unknown. The current study identified that the macrophage is the major microenvironmental component of bone-metastatic PC in patients. Using a novel in vivo model, we demonstrated that macrophages were critical for enzalutamide resistance through induction of a wound-healing–like response of ECM–receptor gene expression. Mechanistically, macrophages drove resistance through cytokine activin A that induced fibronectin (FN1)-integrin alpha 5 (ITGA5)–tyrosine kinase Src (SRC) signaling cascade in PC cells. This novel mechanism was strongly supported by bioinformatics analysis of patient transcriptomics datasets. Furthermore, macrophage depletion or SRC inhibition using a novel specific inhibitor significantly inhibited resistant growth. Together, our findings elucidated a novel mechanism of macrophage-induced anti-androgen resistance of metastatic PC and a promising therapeutic approach to treat this deadly disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Reproductive Health, College of Medicine and Veterinary Medicine, Queen's Medical Research Institute, The University of Edinburgh , Edinburgh, UK.
- Human Phenome Institute, Zhangjiang Fudan International Innovation Center, Fudan University , Shanghai, China.
- BGI-Shenzhen , Shenzhen, China.
- BGI-Henan, BGI-Shenzhen , Xinxiang, China.
- Department of Urology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medicine School, Central South University , Changsha, China.
- Department of Urology, The Second Xiangya Hospital, Central South University , Changsha, China.
ORCID-Profile: Xue-Feng Li, Cigdem Selli, Han-Lin Zhou, Jian Cao, Shuiqing Wu, Ruo-Yu Ma, Ye Lu, Cheng-Bin Zhang, Bijie Xun, Alyson D Lam, Xiao-Cong Pang, Anu Fernando, Zeda Zhang, Asier Unciti-Broceta, Neil O Carragher, Prakash Ramachandran, Neil C Henderson, Ling-Ling Sun, Hai-Yan Hu, Gui-Bo Li, Charles Sawyers, Bin-Zhi Qian
Förderung
- Medical Research Council
- Howard Hughes Medical Institute
- NCI NIH HHS
- Wellcome Trust
- European Research Council
- Fellowship of China Postdoctoral Science Foundation
- International Postdoctoral Exchange Fellowship Program
- Natural Science Foundation of China
Zitieren
APA
Li, X. F., Selli, C., Zhou, H. L., Cao, J., Wu, S., Ma, R. Y., Lu, Y., Zhang, C. B., Xun, B., Lam, A. D., Pang, X. C., Fernando, A., Zhang, Z., Unciti-Broceta, A., Carragher, N. O., Ramachandran, P., Henderson, N. C., Sun, L. L., Hu, H. Y., …, & Qian, B. Z. (2023). Macrophages promote anti-androgen resistance in prostate cancer bone disease. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20221007
Vancouver
Li XF, Selli C, Zhou HL, Cao J, Wu S, Ma RY, et al. Macrophages promote anti-androgen resistance in prostate cancer bone disease. Journal of Experimental Medicine. 2023. doi:10.1084/jem.20221007
BibTeX
@article{Li2023,
author = {Li, Xue-Feng and Selli, Cigdem and Zhou, Han-Lin and Cao, Jian and Wu, Shuiqing and Ma, Ruo-Yu and Lu, Ye and Zhang, Cheng-Bin and Xun, Bijie and Lam, Alyson D and Pang, Xiao-Cong and Fernando, Anu and Zhang, Zeda and Unciti-Broceta, Asier and Carragher, Neil O and Ramachandran, Prakash and Henderson, Neil C and Sun, Ling-Ling and Hu, Hai-Yan and Li, Gui-Bo and Sawyers, Charles and Qian, Bin-Zhi},
title = {Macrophages promote anti-androgen resistance in prostate cancer bone disease},
journal = {Journal of Experimental Medicine},
year = {2023},
doi = {10.1084/jem.20221007}
}
EUVIMED